Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: Role of tissue factor pathway inhibitor
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 15 (1) , 60-64
- https://doi.org/10.1053/jcan.2001.20278
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- MONITORING THROMBIN GENERATION WITH PROTHROMBIN FRAGMENT 1.2 ASSAY DURING CARDIOPULMONARY BYPASS SURGERYThrombosis Research, 1996
- The effect of heparin on the regulation of factor Vila-tissue factor activity by tissue factor pathway inhibitorBlood Coagulation & Fibrinolysis, 1996
- Sites of Tissue Factor Pathway Inhibitor (TFPI) and Tissue Factor Expression under Physiologic and Pathologic ConditionsThrombosis and Haemostasis, 1995
- Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypassThe Lancet, 1994
- Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular MarkersAnesthesiology, 1994
- Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments]Blood, 1993
- Tissue factor is expressed on monocytes during simulated extracorporeal circulation.Circulation Research, 1993
- Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharidesBlood, 1992
- Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patientsBlood Coagulation & Fibrinolysis, 1991
- Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin- alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypassBlood, 1989